Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;86(5):768-778.
doi: 10.1016/j.gie.2017.08.006. Epub 2017 Sep 20.

EUS and related technologies for the diagnosis and treatment of pancreatic disease: research gaps and opportunities-Summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop

Linda S Lee  1 , Dana K Andersen  2 , Reiko Ashida  3 , William R Brugge  4 , Mimi I Canto  5 , Kenneth J Chang  6 , Suresh T Chari  7 , John DeWitt  8 , Joo Ha Hwang  9 , Mouen A Khashab  5 , Kang Kim  10 , Michael J Levy  7 , Kevin McGrath  11 , Walter G Park  12 , Aatur Singhi  13 , Tyler Stevens  14 , Christopher C Thompson  1 , Mark D Topazian  7 , Michael B Wallace  15 , Sachin Wani  16 , Irving Waxman  17 , Dhiraj Yadav  12 , Vikesh K Singh  5
Affiliations
Review

EUS and related technologies for the diagnosis and treatment of pancreatic disease: research gaps and opportunities-Summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop

Linda S Lee et al. Gastrointest Endosc. 2017 Nov.

Abstract

A workshop was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases to address the research gaps and opportunities in pancreatic EUS. The event occurred on July 26, 2017 in 4 sessions: (1) benign pancreatic diseases, (2) high-risk pancreatic diseases, (3) diagnostic and therapeutics, and (4) new technologies. The current state of knowledge was reviewed, with identification of numerous gaps in knowledge and research needs. Common themes included the need for large multicenter consortia of various pancreatic diseases to facilitate meaningful research of these entities; to standardize EUS features of different pancreatic disorders, the technique of sampling pancreatic lesions, and the performance of various therapeutic EUS procedures; and to identify high-risk disease early at the cellular level before macroscopic disease develops. The need for specialized tools and accessories to enable the safe and effective performance of therapeutic EUS procedures also was discussed.

PubMed Disclaimer

Comment in

References

    1. Dimagno EP, Regan PT, Clain JE, et al. Human endoscopic ultrasonography. Gastroenterology 1982;83:824–9. - PubMed
    1. Hisanaga K, Hisanaga A, Ichie Y, et al. Transoesophageal pulsed Doppler echocardiography. Lancet 1979;1:53–4. - PubMed
    1. Hisanaga K, Hisanaga A, Nagata K, et al. High speed rotating scanner for transgastric sonography. AJR Am J Roentgenol 1980;135:627–9. - PubMed
    1. McClaine RJ, Lowy AM, Sussman JJ, et al. Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer. HPB (Oxford) 2010;12:73–9. - PMC - PubMed
    1. Ngamruengphong S, Swanson KM, Shah ND, et al. Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer. Gut 2015;64:1105–10. - PubMed

MeSH terms